The Centers for Disease Control and Prevention today released a describing the characteristics of multisystem inflammatory syndrome (MIS-C), a rare but serious condition that states have reported in more than 500 children with COVID-19.

According to the report, most MIS-C cases have features of shock, with cardiac involvement, gastrointestinal symptoms and significantly elevated markers of inflammation.

鈥淎s the COVID-19 pandemic continues, with the number of cases increasing in many jurisdictions, health care providers should continue to monitor patients to identify children with a hyperinflammatory syndrome with shock and cardiac involvement,鈥 the authors said. 鈥淪uspected MIS-C patients should be reported to local and state health departments.鈥

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
 The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥